Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
                        Cellcure Cancer Centre Private Limited, is an unlisted private company incorporated on 25 October, 2017. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR  3.57 cr and the total paid-up capital is INR  1.88 cr.
Cellcure Cancer Centre's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2024. It's book networth has increased by 24.72%.
                    
                    Read more
                    
                
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address | 
|---|
| Designation | Name | DIN/PAN | Tenure | 
|---|---|---|---|
| Director | Preetam Baban Kalaskar 
                                     Shareholder
                                 | 07958660 | 8 years | 
| Director | Ashish Anand Joshi 
                                     Shareholder
                                 | 07958653 | 8 years | 
| Director | Kshitij Chandrakant Joshi 
                                     Shareholder
                                 | 07958657 | 8 years | 
| Director | Vashista Pankaj Maniar 
                                     Shareholder
                                 | 07958648 | 8 years | 
| Director | Vamesh Chovatia | 00372525 | 3 years | 
| Director | Mayank Khanduja | 03579776 | 1 years | 
| Director | Bhavin Ashokbhai Shah | 00020223 | 1 years | 
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO | 
As per information available, the company has no registered charges.
| Name | State / Country | Incorporation Year | Paidup Capital | 
|---|---|---|---|
| CELLCURE MEDICARE PRIVATE LIMITED | Maharashtra | 2017 | ₹ 1.0 L | 
| CERTAINCURE PHARMA PRIVATE LIMITED | Maharashtra | 2019 | ₹ 1.0 L | 
                Read more
                
            
The incorporation date of CELLCURE CANCER CENTRE PRIVATE LIMITED is 25 October, 2017
The authorized share capital of CELLCURE CANCER CENTRE PRIVATE LIMITED is INR ₹ 3.6 Cr.
The paid-up capital of CELLCURE CANCER CENTRE PRIVATE LIMITED is INR ₹ 1.9 Cr.
The registered address of CELLCURE CANCER CENTRE PRIVATE LIMITED is 1st & 2nd Floor, Shree Saraswati Apartments, CHSL, Opposite Bhagwati Hospital, S.V. Road, Borivali West, Mumbai, Borivali West, Maharashtra, India, 400092 - 400092
The CIN number of CELLCURE CANCER CENTRE PRIVATE LIMITED is U74999MH2017PTC301138.